Patient-Led Decision-Making for HIV Preexposure Prophylaxis

Overview

Journal Curr HIV/AIDS Rep

Publisher Current Science

Specialty Infectious Diseases

Date 2021 Jan 8

PMID 33417201

Citations 15

Authors

Whitney C Sewell

Patricia Solleveld

Dominika Seidman

Christine Dehlendorf

Julia L Marcus

Douglas S Krakower

Affiliations

Soon will be listed here.

Abstract

Purpose Of Review: Shared decision-making is a process that involves bidirectional exchange of information between patients and providers to support patients in making individualized, evidence-based decisions about their healthcare. We review the evidence on patient-led decision-making, a form of shared decision-making that maximizes patient autonomy, as a framework for decisions about HIV preexposure prophylaxis (PrEP). We also assess the likelihood that patient-led decision-making occurs for PrEP and describe interventions to facilitate this process.

Recent Findings: Patient-led decision-making is likely to be uncommon for PrEP, in part because healthcare providers lack knowledge and training about PrEP. Few evidence-based interventions exist to facilitate patient-led decision-making for PrEP. There is a need for rigorously developed interventions to increase knowledge of PrEP among patients and healthcare providers and support patient-led decision-making for PrEP, which will be increasingly important as the range of available PrEP modalities expands.

Citing Articles

Reconciling advantages and difficulties: knowledge and perceptions of event-driven PrEP among young people.

Deus L, Ferraz D, Santos L, Grangeiro A, Dourado I, Couto M Rev Saude Publica. 2024; 58(suppl 1):13s.

PMID: 39417509 PMC: 11573368. DOI: 10.11606/s1518-8787.2020054005729.

We choose: Adolescent girls and young women's choice for an HIV prevention product in a cross-over randomized clinical trial conducted in South Africa, Uganda, and Zimbabwe.

Atujuna M, Williams K, Roberts S, Young A, Browne E, Mangxilana N PLoS One. 2024; 19(8):e0308577.

PMID: 39208281 PMC: 11361692. DOI: 10.1371/journal.pone.0308577.

Evaluating Dual Process Decision-Making Along the PrEP Consumer Journey: New Insights for Supporting PrEP Use.

Lane B, Nguyen N, Fillmore H, Carnevale C, Sobieszczyk M, Zucker J AIDS Behav. 2024; 28(9):2850-2862.

PMID: 38801501 PMC: 11390328. DOI: 10.1007/s10461-024-04357-4.

PrEP for people who use opioids: A NIDA clinical trials network survey study in Southern U.S. cities where HIV incidence is high.

Hatch M, Laschober T, Paschen-Wolff M, Ertl M, Nelson C, Wright L Drug Alcohol Depend. 2024; 257:111133.

PMID: 38447393 PMC: 11131129. DOI: 10.1016/j.drugalcdep.2024.111133.

Social and structural factors associated with interest in HIV preexposure prophylaxis among Black women in the United States.

Irie W, Calabrese S, Mayer K, Geng E, Blackstock O, Marcus J AIDS Care. 2024; 36(5):672-681.

PMID: 38176016 PMC: 10994725. DOI: 10.1080/09540121.2023.2299338.

References

Pleuhs B, Quinn K, Walsh J, Petroll A, John S . Health Care Provider Barriers to HIV Pre-Exposure Prophylaxis in the United States: A Systematic Review. AIDS Patient Care STDS. 2020; 34(3):111-123. PMC: 7087402. DOI: 10.1089/apc.2019.0189. View

Finlayson T, Cha S, Xia M, Trujillo L, Denson D, Prejean J . Changes in HIV Preexposure Prophylaxis Awareness and Use Among Men Who Have Sex with Men - 20 Urban Areas, 2014 and 2017. MMWR Morb Mortal Wkly Rep. 2019; 68(27):597-603. PMC: 6741853. DOI: 10.15585/mmwr.mm6827a1. View

Misra K, Udeagu C . Disparities in Awareness of HIV Postexposure and Preexposure Prophylaxis Among Notified Partners of HIV-Positive Individuals, New York City 2015-2017. J Acquir Immune Defic Syndr. 2017; 76(2):132-140. DOI: 10.1097/QAI.0000000000001473. View

Weymiller A, Montori V, Jones L, Gafni A, Guyatt G, Bryant S . Helping patients with type 2 diabetes mellitus make treatment decisions: statin choice randomized trial. Arch Intern Med. 2007; 167(10):1076-82. DOI: 10.1001/archinte.167.10.1076. View

Grov C, Rendina H, John S, Parsons J . Determining the Roles that Club Drugs, Marijuana, and Heavy Drinking Play in PrEP Medication Adherence Among Gay and Bisexual Men: Implications for Treatment and Research. AIDS Behav. 2018; 23(5):1277-1286. PMC: 6458096. DOI: 10.1007/s10461-018-2309-9. View

Blanc X, Collet T, Auer R, Fischer R, Locatelli I, Iriarte P . Publication trends of shared decision making in 15 high impact medical journals: a full-text review with bibliometric analysis. BMC Med Inform Decis Mak. 2014; 14:71. PMC: 4136407. DOI: 10.1186/1472-6947-14-71. View

Seidman D, Carlson K, Weber S, Witt J, Kelly P . United States family planning providers' knowledge of and attitudes towards preexposure prophylaxis for HIV prevention: a national survey. Contraception. 2016; 93(5):463-9. DOI: 10.1016/j.contraception.2015.12.018. View

Elwyn G, Laitner S, Coulter A, Walker E, Watson P, Thomson R . Implementing shared decision making in the NHS. BMJ. 2010; 341:c5146. DOI: 10.1136/bmj.c5146. View

Dehlendorf C, Fitzpatrick J, Steinauer J, Swiader L, Grumbach K, Hall C . Development and field testing of a decision support tool to facilitate shared decision making in contraceptive counseling. Patient Educ Couns. 2017; 100(7):1374-1381. PMC: 5985808. DOI: 10.1016/j.pec.2017.02.009. View

10.

Seidman D, Weber S, Carlson K, Witt J . Family planning providers' role in offering PrEP to women. Contraception. 2018; 97(6):467-470. PMC: 6010195. DOI: 10.1016/j.contraception.2018.01.007. View

11.

Thigpen M, Kebaabetswe P, Paxton L, Smith D, Rose C, Segolodi T . Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med. 2012; 367(5):423-34. DOI: 10.1056/NEJMoa1110711. View

12.

Makoul G, Clayman M . An integrative model of shared decision making in medical encounters. Patient Educ Couns. 2005; 60(3):301-12. DOI: 10.1016/j.pec.2005.06.010. View

13.

Cottrell M, Yang K, Prince H, Sykes C, White N, Malone S . A Translational Pharmacology Approach to Predicting Outcomes of Preexposure Prophylaxis Against HIV in Men and Women Using Tenofovir Disoproxil Fumarate With or Without Emtricitabine. J Infect Dis. 2016; 214(1):55-64. PMC: 4907409. DOI: 10.1093/infdis/jiw077. View

14.

Calabrese S, Krakower D, Mayer K . Integrating HIV Preexposure Prophylaxis (PrEP) Into Routine Preventive Health Care to Avoid Exacerbating Disparities. Am J Public Health. 2017; 107(12):1883-1889. PMC: 5678380. DOI: 10.2105/AJPH.2017.304061. View

15.

Volk J, Marcus J, Phengrasamy T, Blechinger D, Nguyen D, Follansbee S . No New HIV Infections With Increasing Use of HIV Preexposure Prophylaxis in a Clinical Practice Setting. Clin Infect Dis. 2015; 61(10):1601-3. PMC: 4809999. DOI: 10.1093/cid/civ778. View

16.

Chou R, Evans C, Hoverman A, Sun C, Dana T, Bougatsos C . Preexposure Prophylaxis for the Prevention of HIV Infection: Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2019; 321(22):2214-2230. DOI: 10.1001/jama.2019.2591. View

17.

Hojilla J, Vlahov D, Glidden D, Amico K, Mehrotra M, Hance R . Skating on thin ice: stimulant use and sub-optimal adherence to HIV pre-exposure prophylaxis. J Int AIDS Soc. 2018; 21(3):e25103. PMC: 5867332. DOI: 10.1002/jia2.25103. View

18.

Dehlendorf C, Grumbach K, Schmittdiel J, Steinauer J . Shared decision making in contraceptive counseling. Contraception. 2017; 95(5):452-455. PMC: 5466847. DOI: 10.1016/j.contraception.2016.12.010. View

19.

Joseph-Williams N, Elwyn G, Edwards A . Knowledge is not power for patients: a systematic review and thematic synthesis of patient-reported barriers and facilitators to shared decision making. Patient Educ Couns. 2013; 94(3):291-309. DOI: 10.1016/j.pec.2013.10.031. View

20.

Goparaju L, Praschan N, Warren-Jeanpiere L, Experton L, Young M, Kassaye S . Stigma, Partners, Providers and Costs: Potential Barriers to PrEP Uptake among US Women. J AIDS Clin Res. 2017; 8(9). PMC: 5708581. DOI: 10.4172/2155-6113.1000730. View